
AIM ImmunoTech AIM
€ 0.59
0.0%
Quartalsbericht 2025-Q3
hinzugefügt 17.11.2025
AIM ImmunoTech EV 2011-2026 | AIM
EV Jährlich AIM ImmunoTech
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -6.86 M | 12.1 M | 40.5 M | 9.52 M | 18.1 M | 18.7 M | 15.4 M | 21.6 M | 43.7 M | 75.4 M | 53.1 M | 66.1 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 75.4 M | -6.86 M | 30.6 M |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.82 B | - | 2.43 % | $ 254 M | ||
|
Acer Therapeutics
ACER
|
38.2 M | - | 2.71 % | $ 14 M | ||
|
Acorda Therapeutics
ACOR
|
-13.2 M | - | -24.86 % | $ 820 K | ||
|
ADMA Biologics
ADMA
|
3.84 B | $ 15.87 | -4.08 % | $ 3.78 B | ||
|
AgeX Therapeutics
AGE
|
6.28 M | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
-23.2 M | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-9.16 M | - | - | $ 26.5 M | ||
|
AbCellera Biologics
ABCL
|
1.22 B | $ 3.54 | -2.62 % | $ 1.06 B | ||
|
I-Mab
IMAB
|
8.28 B | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
1.95 B | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
525 M | - | -13.47 % | $ 169 M | ||
|
Aptorum Group Limited
APM
|
9.45 M | $ 0.82 | -0.73 % | $ 4.47 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
3.41 B | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
4.79 M | - | -18.52 % | $ 27.3 M | ||
|
Akero Therapeutics
AKRO
|
2.99 B | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
95.1 M | - | 0.23 % | $ 488 M | ||
|
Alpine Immune Sciences
ALPN
|
363 M | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
-64.1 M | - | 4.14 % | $ 49.1 M | ||
|
Apellis Pharmaceuticals
APLS
|
3.01 B | $ 20.36 | 2.49 % | $ 2.57 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-1.05 M | - | -11.43 % | $ 502 K | ||
|
ANI Pharmaceuticals
ANIP
|
1.91 B | $ 75.13 | -1.83 % | $ 1.45 B | ||
|
Applied Therapeutics
APLT
|
563 M | - | - | $ 8.42 M | ||
|
Autolus Therapeutics plc
AUTL
|
1.11 B | $ 1.51 | -7.36 % | $ 385 M | ||
|
Aravive
ARAV
|
58.2 M | - | -13.39 % | $ 1.45 M | ||
|
Adverum Biotechnologies
ADVM
|
125 M | - | - | $ 86.2 M | ||
|
Институт стволовых клеток человека
ISKJ
|
14.1 M | - | - | - | ||
|
Athersys
ATHX
|
-37.4 M | - | 3.77 % | $ 22.4 M | ||
|
ARCA biopharma
ABIO
|
436 M | - | 1052.0 % | $ 415 M | ||
|
AVEO Pharmaceuticals
AVEO
|
86.9 M | - | - | $ 521 M | ||
|
Axsome Therapeutics
AXSM
|
8.95 B | $ 162.19 | -1.15 % | $ 8.07 B | ||
|
BridgeBio Pharma
BBIO
|
15.5 B | $ 64.72 | -2.73 % | $ 12.4 B | ||
|
Brainstorm Cell Therapeutics
BCLI
|
15.7 M | - | -2.5 % | $ 5.88 M | ||
|
BioDelivery Sciences International
BDSI
|
445 M | - | -4.8 % | $ 255 M | ||
|
Acasti Pharma
ACST
|
24 M | - | 4.01 % | $ 150 M | ||
|
BeiGene, Ltd.
BGNE
|
-720 M | - | 0.49 % | $ 251 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
-9.74 M | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
115 M | - | -7.31 % | $ 87 M | ||
|
CureVac N.V.
CVAC
|
3.19 B | - | - | $ 867 M | ||
|
Aeterna Zentaris
AEZS
|
5.52 M | - | 5.93 % | $ 314 M | ||
|
Bellerophon Therapeutics
BLPH
|
77.1 M | - | -74.18 % | $ 955 K | ||
|
BioLineRx Ltd.
BLRX
|
15 M | $ 2.86 | 1.78 % | $ 908 M | ||
|
BioMarin Pharmaceutical
BMRN
|
11.9 B | $ 60.15 | -0.46 % | $ 11.5 B | ||
|
Equillium
EQ
|
89.5 M | $ 1.7 | -3.14 % | $ 59 M | ||
|
Burford Capital Limited
BUR
|
3.22 B | $ 8.29 | -1.02 % | $ 1.35 B | ||
|
Cabaletta Bio
CABA
|
-155 M | $ 3.3 | -3.89 % | $ 3.85 M | ||
|
AIkido Pharma
AIKI
|
22.8 M | - | 1.93 % | $ 17.4 M | ||
|
Agenus
AGEN
|
-75.9 M | $ 3.02 | -5.63 % | $ 1.08 M | ||
|
Ayala Pharmaceuticals
AYLA
|
5.32 M | - | - | $ 7.46 M | ||
|
Capricor Therapeutics
CAPR
|
177 M | $ 25.16 | -1.33 % | $ 674 M | ||
|
Agios Pharmaceuticals
AGIO
|
1.65 B | $ 27.77 | -1.49 % | $ 1.61 B |